Furthermore, inhibition of JAK by tofacitinib markedly ameliorated fibrosis development in both bleomycin-induced SSc mice and TSK1/+ mice, suggesting a critical role of JAK-STAT signaling in fibrotic changes of SSc [141]. This evidence concerns the gene TSSK1B and systemic sclerosis.